| SKU | CT-86 |
| Color | Luscious Blackberry |
Advanced Biologic Therapy with Stelara 130 mg
Stelara (Ustekinumab) 130 mg/26 mL represents a sophisticated breakthrough in biologic therapy. Engineered for patients requiring precise intervention, this concentrate is specifically designed to be diluted for intravenous infusion, offering a highly targeted approach to managing chronic inflammatory conditions.
Why Choose Stelara for Your Treatment Plan?
Stelara is a human monoclonal antibody that selectively targets interleukin-12 (IL-12) and interleukin-23 (IL-23), two cytokines that play a key role in the body's immune response and inflammatory processes. By inhibiting these targets, Stelara helps provide significant relief and disease control for patients struggling with inflammatory conditions.
Key Therapeutic Benefits
- Targeted Efficacy: Precisely identifies and inhibits IL-12 and IL-23, effectively addressing the underlying inflammatory pathways.
- Proven Control: Offers sustained relief and long-term management for chronic inflammatory diseases.
- Professional Formulation: Provided as a 130 mg/26 mL concentrate, ensuring accurate dosing when prepared for intravenous infusion.
- Trusted Innovation: Developed by Janssen, a global leader in medical biotechnology and immunology.
Commitment to Pharmaceutical Excellence
As a premium biologic product from Janssen, Stelara is manufactured under rigorous international quality and safety protocols. Every vial is crafted to maintain the stability and integrity of the Ustekinumab molecule, ensuring that you receive the full therapeutic potential of your prescribed treatment.
Stelara is a potent prescription-only biologic medicine. Preparation and administration must be performed by a qualified healthcare professional in a clinical setting. Please follow your specialist’s instructions precisely regarding your treatment schedule and monitoring. Keep this medication refrigerated, do not freeze, and keep strictly out of the reach of children.
